UBS O'Connor’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-21,499
Closed -$3M 301
2025
Q2
$3M Buy
21,499
+18,193
+550% +$2.55M 0.08% 114
2025
Q1
$486K Sell
3,306
-27,418
-89% -$3.97M 0.01% 223
2024
Q4
$4.03M Buy
+30,724
New +$4.3M 0.1% 99
2024
Q3
Hold
0
516
2024
Q2
Sell
-27,142
Closed -$4.08M 552
2024
Q1
$3.68M Buy
27,142
+11,108
+69% +$1.47M 0.11% 109
2023
Q4
$2.16M Sell
16,034
-8,737
-35% -$1.14M 0.07% 161
2023
Q3
$3.35M Buy
24,771
+8,000
+48% +$1.09M 0.06% 169
2023
Q2
$2.4M Sell
16,771
-5,829
-26% -$858K 0.05% 247
2023
Q1
$3.14M Buy
+22,600
New +$3.04M 0.07% 200
2022
Q4
Sell
-48,215
Closed -$5.29M 51
2022
Q3
$5.29M Buy
48,215
+7,500
+18% +$951K 0.06% 202
2022
Q2
$5.38M Buy
+40,715
New +$5.34M 0.06% 214
2015
Q1
Sell
-88,398
Closed -$6.22M 730
2014
Q4
$6.22M Hold
88,398
0.11% 182
2014
Q3
$6.32M Hold
88,398
0.11% 194
2014
Q2
$6.57M Buy
+88,398
New +$6.39M 0.04% 177

Other funds holding AZN